Loading clinical trials...
Loading clinical trials...
Open-Label Extension Study of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps
Conditions
Interventions
Omalizumab
Placebo
Locations
79
United States
Clinical Research Center of Alabama, LLC
Birmingham, Alabama, United States
Banner University of Arizona Medical Center
Tucson, Arizona, United States
Jonathan Corren MD, Inc.
Los Angeles, California, United States
The Allergy Station at Sacramento ENT
Roseville, California, United States
Bensch Clinical Research LLC
Stockton, California, United States
Colorado ENT & Allergy
Colorado Springs, Colorado, United States
Start Date
May 9, 2018
Primary Completion Date
March 16, 2020
Completion Date
March 16, 2020
Last Updated
April 4, 2022
NCT04469439
NCT06914908
NCT05246267
NCT07340411
NCT07125586
NCT07268313
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions